2018 Annual CFAR Scientific Symposium: Opioids and HIV


The purpose of this meeting is to update the San Francisco Bay Area (HIV research) community on the opioid epidemic and the current state of the science, especially as it pertains to HIV. We envision a broad scope covering national epidemiology and trends, an overview of the drug market (heroin versus fentanyl, an overview of clinical interventions available, a panel discussions on innovative uses of buprenorphine and safe consumption spaces, current research and interventions happening at the Veterans Affairs Medical Center, and policy and social justice developments.

Program Agenda

Understanding Changes in the US ‘Heroin’ Market: Notes from the Field
Daniel Ciccarone, MD, MPH
Professor, Family & Community Medicine, UCSF

The Evolving Epidemiology of HIV Infection in Person who Inject Drugs: Lessons Learned from Indiana 2015
John T. Brooks, MD
Medical Epidemiologist, Division of HIV/AIDS Prevention, CDC

Panel Discussion: Safe Consumption Spaces
Laura Thomas, MPH, MPP
Interim State Director, California, Drug Policy Alliance
Alex H. Kral, PhD
Principal Scientist, Behavioral Health and Criminal Justice Division, RTI
Paula Lum, MD, MPH, FASAM
Professor of Medicine, UCSF
Holly Bradford
Program Coordinator, San Francisco Drug Users’ Union

Conditions of Possibility: Harm Reductionas a Pathway to Healing the Harms Caused by Racialized Drug Policies
Monique Tula
Executive Director, Harm Reduction Coalition

Clinical Interventions to Address the Opioid-Infectious Disease Syndemic
Alexander Walley, MD, MSc
Associate Professor, Medicine, Boston University

Panel Discussion: Out Of The Box Care For Persons Who Use Drugs
Starting Buprenorphine in the ER
Andrew Herring, MD
Director of Emergency Pain and Addiction Treatment, Highland Hospital

Low Threshold Buprenorphine Access
Barry Zevin, MD

Medical Director, Street Medicine and Shelter Health, SFDPH
(TBC) Jamie Carter, MD, MPH
UCSF Primary Care Addiction Medicine Fellow, Tom Waddell Urban Health Clinic

The 6th Street Model of HCV Care
Pauli Gray
Senior HCV Coordinator/Harm Reduction Specialist, San Francisco AIDS Foundation/Syringe Access Services
Pierre-Cedric Crouch, PhD, ANP-BC, ACRN
Director of Nursing at Magnet, San Francisco AIDS Foundation

Moving Beyond MEDD and Opioids to Address the Opioid Crisis
Elizabeth M. Oliva, PhD
VA National Opioid Overdose Education and Naloxone Distribution Coordinator
VA Program Evaluation and Resource Center
VA Office of Mental Health and Suicide Prevention
Investigator, Center for Innotvative Implementation (Ci2i)
VA Palo Alto Health Care System

Unintended Consequences of the Opioid Epidemic on Clinician Practice
Philip Coffin, MD, MIA, FACP
Director of Substance Use Research, SFDPH